City Clinical Oncology Hospital No 1
2 clinical trials · Sponsor
◉ Watch City Clinical Oncology Hospital No 1
| Record | Firm | Date |
|---|---|---|
| Other Oncogene Mutations for Anti-EGFR Efficacy in Patients With Left-sided RAS-wild Type Metastatic Colorectal Cancer (NCT06226857) | City Clinical Oncology Hospital No 1 | 2024-01-17 |
| Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer (NCT05551767) | City Clinical Oncology Hospital No 1 | 2022-08-30 |
Track City Clinical Oncology Hospital No 1 automatically
Every clearance here is in the API, with alerts when new ones post.